Karin Milde‐Langosch

7.0k total citations
130 papers, 5.6k citations indexed

About

Karin Milde‐Langosch is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Karin Milde‐Langosch has authored 130 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 66 papers in Oncology and 27 papers in Cancer Research. Recurrent topics in Karin Milde‐Langosch's work include Cancer-related Molecular Pathways (32 papers), Cancer Cells and Metastasis (15 papers) and Cervical Cancer and HPV Research (13 papers). Karin Milde‐Langosch is often cited by papers focused on Cancer-related Molecular Pathways (32 papers), Cancer Cells and Metastasis (15 papers) and Cervical Cancer and HPV Research (13 papers). Karin Milde‐Langosch collaborates with scholars based in Germany, United States and Russia. Karin Milde‐Langosch's co-authors include Thomas Löning, Volkmar Müller, Ana‐Maria Bamberger, Klaus Pantel, Heidi Schwarzenbach, Leticia Oliveira‐Ferrer, Sabine Riethdorf, F. Jänicke, Fabian Trillsch and Karen Legler and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Karin Milde‐Langosch

128 papers receiving 5.5k citations

Peers

Countries citing papers authored by Karin Milde‐Langosch

Since Specialization

Citations

This map shows the geographic impact of Karin Milde‐Langosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Milde‐Langosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Milde‐Langosch more than expected).

Fields of papers citing papers by Karin Milde‐Langosch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Milde‐Langosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Milde‐Langosch. The network helps show where Karin Milde‐Langosch may publish in the future.

Co-authorship network of co-authors of Karin Milde‐Langosch

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Milde‐Langosch. A scholar is included among the top collaborators of Karin Milde‐Langosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Milde‐Langosch. Karin Milde‐Langosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients 2023 ·Cancer Cell International ·(unknown), (unknown), Karen Legler, Thomas Karn, Serenella Eppenberger‐Castori, Jakob Matschke, Thais Pereira‐Veiga, Harriet Wikman, Isabell Witzel, Volkmar Müller, Barbara Schmalfeldt, Karin Milde‐Langosch, Udo Schumacher, (unknown), Leticia Oliveira‐Ferrer	4
2	Relevance of βGal–βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients 2015 ·Breast Cancer Research and Treatment ·Karin Milde‐Langosch, (unknown), Leticia Oliveira‐Ferrer, Harriet Wikman, Volkmar Müller, Patrick Lebok, Klaus Pantel, Christine Schröder, Isabell Witzel, Udo Schumacher	30
3	Relevance of glycosylation-associated genes for tumor progression and metastasis localization in breast cancer 2015 ·Annals of Oncology ·Leticia Oliveira‐Ferrer, (unknown), Isabell Witzel, Thomas Karn, Ralph M. Wirtz, Veronika Müller, Karin Milde‐Langosch	1
4	Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function 2015 ·Molecular and Clinical Oncology ·(unknown), Leticia Oliveira‐Ferrer, Thomas Löning, Fabian Trillsch, Sven Mahner, Karin Milde‐Langosch	6
5	Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers 2013 ·Journal of Cancer Research and Clinical Oncology ·Isabell Witzel, Monika Graeser, Thomas Karn, M Schmidt, Ralph M. Wirtz, (unknown), (unknown), F. Jänicke, Karin Milde‐Langosch, Volkmar Müller	30
6	Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer 2012 ·Breast Cancer Research and Treatment ·Karin Milde‐Langosch, Thomas Karn, Volkmar Müller, Isabell Witzel, Achim Rody, Markus Schmidt, Ralph M. Wirtz	62
7	Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease 2011 ·Molecular BioSystems ·Heidi Schwarzenbach, Volkmar Müller, Karin Milde‐Langosch, Bettina Steinbach, Klaus Pantel	55
8	Management of Patients with Brain Metastases Receiving Trastuzumab Treatment for Metastatic Breast Cancer 2011 ·Onkologie ·Isabell Witzel, Eva Johanna Kantelhardt, Karin Milde‐Langosch, Maike Ihnen, (unknown), Nadia Harbeck, F. Jänicke, Volkmar Müller	19
9	Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases. 2010 ·SHILAP Revista de lepidopterología ·Maike Ihnen, (unknown), (unknown), Karin Milde‐Langosch, (unknown), Sylvia Höller, Volkmar Müller, Isabell Witzel, F. Jänicke, (unknown)	15
10	The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells 2010 ·European Journal of Cancer ·Christine Schröder, Udo Schumacher, Volkmar Müller, Ralph M. Wirtz, Thomas Streichert, Ulrich Richter, Daniel Wicklein, Karin Milde‐Langosch	31
11	Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas. 2009 ·PubMed ·(unknown), Thomas Löning, Volkmar Müller, Christine Schröder, F. Jänicke, Karin Milde‐Langosch	18
12	Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients 2008 ·British Journal of Cancer ·Jens Panse, Kay Friedrichs, Alexander Marx, York Hildebrandt, Tim Luetkens, Katrin Bartels, Carsten Horn, Tanja Stahl, Yan Cao, Karin Milde‐Langosch, Axel Niendorf, Nicolaus Kröger, Stefan Wenzel, R. Leuwer, Carsten Bokemeyer, S. Hegewisch-Becker, Djordje Atanackovic	100
13	The Fos family of transcription factors and their role in tumourigenesis 2005 ·European Journal of Cancer ·Karin Milde‐Langosch	452
14	The Role of the AP-1 Transcription Factors c-Fos, FosB, Fra-1 and Fra-2 in the Invasion Process of Mammary Carcinomas 2004 ·Breast Cancer Research and Treatment ·Karin Milde‐Langosch, (unknown), Birte Andritzky, (unknown), (unknown), (unknown), Christoph M. Bamberger, Thomas Löning, Ana‐Maria Bamberger	105
15	The Glucocorticoid Receptor Is Specifically Expressed in the Stromal Compartment of the Human Endometrium 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Ana‐Maria Bamberger, Karin Milde‐Langosch, (unknown), Christoph M. Bamberger	47
16	PTEN Expression in Breast and Endometrial Cancer: Correlations with Steroid Hormone Receptor Status 2001 ·Pathobiology ·(unknown), (unknown), Ana‐Maria Bamberger, Thomas Löning, Karin Milde‐Langosch	16
17	Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications 2000 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Karin Milde‐Langosch, Sabine Riethdorf, Thomas Löning	37
18	Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer 1997 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·B. Lisboa, (unknown), (unknown), Lutz Riethdorf, Karin Milde‐Langosch, Thomas Löning	23
19	HPV DNA and p53 alterations in oropharyngeal carcinomas 1995 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·M Barten, (unknown), (unknown), P. M�ller, (unknown), Karin Milde‐Langosch	26
20	[Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas]. 1991 ·PubMed ·Karin Milde‐Langosch, (unknown), Thomas Brack, Thomas Löning	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact